Code Snippets
curl "https://financialdata.net/api/v1/income-statements?identifier=GILD&period=year&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/income-statements?identifier=GILD&period=year&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/income-statements?identifier=GILD&period=year&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "GILD",
"central_index_key": "0000882095",
"registrant_name": "GILEAD SCIENCES, INC.",
"fiscal_year": "2025",
"fiscal_period": "FY",
"period_end_date": "2025-12-31",
"revenue": 29443000000.0,
"cost_of_revenue": 6234000000.0,
"gross_profit": 23209000000.0,
"research_and_development_expenses": 5799000000.0,
"general_and_administrative_expenses": 5774000000.0,
"operating_expenses": 19421000000.0,
"operating_income": 10022000000.0,
"interest_expense": 1024000000.0,
"interest_income": null,
"net_income": 8510000000.0,
"earnings_per_share_basic": 6.84,
"earnings_per_share_diluted": 6.78,
"weighted_average_shares_outstanding_basic": 1244000000,
"weighted_average_shares_outstanding_diluted": 1255000000
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security, or the central index key (CIK). The latter is assigned to the entity by the United States Securities and Exchange Commission. (e.g., MSFT, 0000789019) |
| period | string | (Optional) The accounting period for which the entity's financial statements are prepared. By default, statements are returned for all accounting periods. (e.g., year, quarter) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 50) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
An income statement, also called a profit and loss statement, is a financial statement that shows a company's income and expenses over a period of time. It indicates how revenue is turned into net income, or profit. Using our API, you can access all the individual financial items that make up an income statement. There is a limit of 50 records per API call.
Company Profile
GILEAD SCIENCES, INC.
NASDAQ: GILD- Market Cap:$103.20B
- ISIN:US3755581036
- Fiscal Year End:12/31
- CEO:Daniel O'Day
- Employees:17000
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
GILD Datasets
GILD Stock QuotesGILD Stock PricesGILD Minute PricesGILD Company InformationGILD Key MetricsGILD Market CapGILD Employee CountGILD Executive CompensationGILD Balance Sheet StatementsGILD Cash Flow StatementsGILD Insider TransactionsGILD Senate TradingGILD Institutional HoldingsGILD Analyst ConsensusGILD Earnings ReleasesGILD Stock SplitsGILD DividendsGILD Short Interest